Christopher Richard Anzalone, Chief Executive Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 130,000 shares at $65.57 ($8.5M) on 2021-10-22, disclosed to the SEC on 2021-10-22.
Open-market sale of $8.5M ARWR by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.23 | 15,000 | $993K | 11.6% |
| 2 | $66.23 | 15,000 | $993K | 11.6% |
| 3 | $65.57 | 44,170 | $2.9M | 33.9% |
| 4 | $65.57 | 44,170 | $2.9M | 33.9% |
| 5 | $66.09 | 5,830 | $385K | 4.5% |
| 6 | $66.09 | 5,830 |
| $385K |
| 4.5% |
| Total | $65.77 avg | 130,000 | $8.5M | 100% |
| Filing → |
| ARWR | SELL | 2025-12-23 | $3.5M | — | Filing → |
| ARWR | SELL | 2025-12-19 | $10.9M | — | Filing → |
| ARWR | SELL | 2025-12-16 | $24.6M | — | Filing → |